Metastatic Tumors

9 registered clinical trials studyying Metastatic Tumors.

Status	Trial	Sponsor	Phase
Unknown	A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in NCT05390528	Shanghai Henlius Biotech	Phase 1 / Phase 2
Active Not Recruiting	Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer NCT03862911	British Columbia Cancer Agency	N/A
Active Not Recruiting	Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors NCT03721341	David Palma	Phase 3
Active Not Recruiting	Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases NCT02933242	British Columbia Cancer Agency	N/A
Completed	Phase 1 Study of OTS167 in Patients With Solid Tumors NCT01910545	OncoTherapy Science, Inc.	Phase 1
Completed	Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors NCT02156388	Jiangsu T-Mab Biopharma Co.,Ltd	Phase 1
Active Not Recruiting	Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) NCT01446744	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 2
Completed	Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors NCT00676949	Kyushu University	Phase 1
Completed	Radiofrequency Ablation of Tumors NCT00705497	St. Jude Children's Research Hospital	Phase 1